Stockreport

Merida launches with $121m to target autoimmune antibodies [Yahoo! Finance]

Immunovant, Inc.  (IMVT) 
PDF The financing round was co-led by Bain Capital Life Sciences, BVF Partners, and Third Rock Ventures, with participation from GV and Perceptive Xontogeny Venture (PXV) F [Read more]